Skip to main content
SpringerLink
Log in

Where is the money? Insights into China’s post-COVID healthcare corruption-busting campaign

  • Letter to the Editors
  • Published:
Journal of Public Health Policy Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Availability of data and materials

Data are available upon reasonable request.

References

  1. Transparency International. Health and corruption. 2023. https://www.transparency.org/en/our-priorities/health-and-corruption. Accessed 1 Oct 2023.

  2. García PJ. Corruption in global health: the open secret. Lancet. 2019;394(10214):2119–24.

    Article  Google Scholar 

  3. Zhang Y, Yu Y-S, Tang Z-H, Chen X-H, Zang G-Q. Crack down on medical corruption: an urgent matter in China. Eur J Intern Med. 2014;25(1):e2–3.

    Article  Google Scholar 

  4. Light DW, Lexchin J, Darrow JJ. Institutional corruption of pharmaceuticals and the myth of safe and effective drugs. J Law Med Ethics. 2013;41(3):590–600.

    Article  Google Scholar 

  5. Zhu W, Wang L, Yang C. Corruption or professional dignity: An ethical examination of the phenomenon of “red envelopes” (monetary gifts) in medical practice in China. Dev World Bioeth. 2018;18(1):37–44.

    Article  Google Scholar 

  6. Yuan S. China’s crackdown on health-care corruption. Lancet. 2023;402(10403):681–2.

    Article  Google Scholar 

  7. The Economist. China’s government launches a campaign against medical corruption. 2023. https://www.economist.com/china/2023/09/14/chinas-government-launches-a-campaign-against-medical-corruption. Accessed 21 Sept 2023.

  8. Yang Z, Fan D. How to solve the crisis behind Bribegate for Chinese doctors. Lancet. 2012;379(9812):e13–5.

    Article  Google Scholar 

  9. Su Z, McDonnell D, Cheshmehzangi A, Abbas J, Li X, Cai Y. The promise and perils of Unit 731 data to advance COVID-19 research. BMJ Glob Health. 2021;6(5):e004772.

    Article  Google Scholar 

  10. Shuster E. The Nuremberg Code: Hippocratic ethics and human rights. Lancet. 1998;351(9107):974–7.

    Article  Google Scholar 

Download references

Acknowledgements

The authors wish to express their gratitude to the editor and reviewers for their constructive insights and kind feedback.

Funding

None.

Author information

Authors and Affiliations

  1. School of Public Health, Institute for Human Rights, Southeast University, Nanjing, 210009, China

    Zhaohui Su, Xin Yu, Jianlin Jiang & Yifan Liu

  2. Bioengineering Research Group, Cardiff School of Technologies, Cardiff Metropolitan University, Cardiff, UK

    Barry L. Bentley

  3. Collaboration for the Advancement of Sustainable Medical Innovation, University College London, London, UK

    Barry L. Bentley

  4. Department of Humanities, South East Technological University, Carlow, R93 V960, Ireland

    Dean McDonnell

  5. Center of Innovation for Education and Research (CIER), Qingdao City University, Qingdao, China

    Ali Cheshmehzangi

  6. Network for Education and Research On Peace and Sustainability (NERPS), Hiroshima University, Hiroshima, 739-8530, Japan

    Ali Cheshmehzangi

  7. Fundação Dom Cabral - FDC, Av. Princesa Diana, 760 Alphaville, Lagoa dos Ingleses, Nova Lima, MG, 34018-006, Brazil

    Ali Cheshmehzangi

  8. Unit of Psychiatry, Department of Public Health and Medicinal Administration; Institute of Translational Medicine, Faculty of Health Sciences; Centre for Cognitive and Brain Sciences; Institute of Advanced Studies in Humanities and Social Sciences, University of Macau, Macao, SAR, China

    Claudimar Pereira da Veiga & Yu-Tao Xiang

Authors
  1. Zhaohui Su
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Barry L. Bentley
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xin Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jianlin Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yifan Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Dean McDonnell
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ali Cheshmehzangi
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Claudimar Pereira da Veiga
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Yu-Tao Xiang
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

ZS, BLB, XY, JJ, YL, DMD, AC, CPdV, and YTX conceived the work, reviewed the literature, drafted, and edited the manuscript. All authors approved the manuscript for submission.

Corresponding authors

Correspondence to Zhaohui Su or Yu-Tao Xiang.

Ethics declarations

Competing interests

Authors declare that they have no Competing interests.

Ethical approval

Not applicable.

Consent to participate

Not applicable.

Consent for publication

Not applicable.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Su, Z., Bentley, B.L., Yu, X. et al. Where is the money? Insights into China’s post-COVID healthcare corruption-busting campaign. J Public Health Pol (2024). https://doi.org/10.1057/s41271-024-00474-5

Download citation

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1057/s41271-024-00474-5

Search

Navigation